Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668664 · ClinicalTrials.gov registry record
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements
A clinical trial of Liver Diseases and Liver Cirrhosis, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 70
- Enrollment target
- 7
- Study locations
NCT04668664 is a study of Liver Diseases and Liver Cirrhosis that has completed, run by Cook Research Incorporated. The registered enrollment target is 70 participants, below the 61,156-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT04668664, a study of Liver Diseases and Liver Cirrhosis, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of the study is to collect and report technical success of direct endoscopic ultrasound guided hepatic and portal vein pressure measurement obtained with EchoTip® Insight™ in patients with cirrhosis who are referred for an EGD and/or EUS.
Conditions Studied
Interventions
- DEVICE EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™)
Study Locations (7)
Other
- Royal Brisbane Women's Hospital - Herston
- Prince of Wales Hospital/Chinese University of Hong Kong - Shatin
California
- University of California, Irvine - Orange
Kansas
- The University of Kansas Health System - Kansas City
Massachusetts
- Brigham & Women's Hospital - Boston
New York
- New York-Presbyterian Hospital/Weill Cornell University Medical Center - New York
Virginia
- University of Virginia Medical Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-04-05 |
| Est. Completion | 2022-06-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04668664
The ClinicalTrials.gov registry entry for NCT04668664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,156-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™) is the first listed.
NCT04668664 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Other, California, Kansas.
Frequently Asked Questions
What is clinical trial NCT04668664 about?
NCT04668664 is a clinical study titled "Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements". The objective of the study is to collect and report technical success of direct endoscopic ultrasound guided hepatic and portal vein pressure measurement obtained with EchoTip® Insight™ in patients with cirrhosis who are referred for an EGD and/or EUS.
What is the current status of trial NCT04668664?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2021-04-05. Estimated completion is 2022-06-13.
What conditions does trial NCT04668664 study?
This clinical trial studies the following conditions: Liver Diseases, Liver Cirrhosis, Hypertension, Portal.
What interventions are being tested in trial NCT04668664?
The interventions under investigation include: EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™) (DEVICE).
Who is sponsoring clinical trial NCT04668664?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04668664 being conducted?
This trial has 7 study locations across California, Kansas, Massachusetts, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
RECRUITING
-
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
RECRUITING · Phase 1
-
Genetic Collection Protocol
RECRUITING
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.